AUPH   $7.06  -1.53% Market Closed After Close 7.01 -0.71%

Aurinia Pharmaceuticals Inc
Total Cash 330.33M
totalCashPerShare 2.31
EBITDA -27.15M
Total Debt 85.98M
quickRatio 4.627
currentRatio 5.327
Total Revenue 207.10M
debtToEquity 23.582
Revenue/Share 1.443
ROA -0.054840002
ROE -0.13304
grossProfits
freeCashflow 26.55M
operatingCashflow -1.72M
earningsGrowth
revenueGrowth 0.378
grossMargins 0.69924
ebitdaMargins -0.13108
operatingMargins -0.0077100005
profitMargins -0.24311
enterpriseValue 760.88M
forwardPE 16.738096
floatShares 128.58M
sharesOutstanding 142.99M
sharesShort 7.24M
sharesShortPriorMonth 8.71M
dateShortInterest
sharesPercentSharesOut 0.05%
heldPercentInsiders 0.07%
heldPercentInstitutions 0.44%
Short Ratio help_outline 5.52%
shortPercentOfFloat 0.05%
impliedSharesOutstanding
bookValue 2.55
Price To Book help_outline 2.76
earningsQuarterlyGrowth
netIncomeToCommon -50.35M
trailingEps -0.35%
forwardEps 0.42%
enterpriseToEbitda -28.03
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.01 3Q 2024
institutionsCount 242
lastUpdated Oct. 21, 2024, 2:33 p.m.